📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

An In Vitro Whole-Organ Liver Engineering for Testing of Genetic Therapies. (2020)

First Author: Lorvellec M

Attributed to: Phase I/II clinical trial evaluating AAV-mediated gene therapy for a severe paediatric metabolic liver disease: Ornithine Transcarbamylase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2020.101808

PubMed Identifier: 33305175

Publication URI: http://europepmc.org/abstract/MED/33305175

Type: Journal Article/Review

Volume: 23

Parent Publication: iScience

Issue: 12

ISSN: 2589-0042